G. Campbell

Mutations in human breast cancer: an overview.

R. Callahan, G. Campbell, Robert Callahan, 1989, Journal of the National Cancer Institute.

Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified.

R. Lidereau, C. Cropp, R. Callahan, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Host genetic background effect on the frequency of mouse mammary tumor virus-induced rearrangements of the int-1 and int-2 loci in mouse mammary tumors

A. Marchetti, F. Buttitta, R. Callahan, 1991, Journal of virology.

HostGenetic Background Effect ontheFrequency ofMouse MammaryTumorVirus-Induced Rearrangements oftheint-i andint-2 LociinMouseMammaryTumors

F. Buttitta, R. Callahan, G. Campbell, 1991 .

NME1 protein expression and loss of heterozygosity mutations in primary human breast tumors.

P. Steeg, R. Lidereau, C. Cropp, 1994, Journal of the National Cancer Institute.

Lack of evidence for the prognostic significance of c-erbB-2 amplification in human breast carcinoma.

R. Lidereau, I. Ali, R. Callahan, 1988, Oncogene research.

Combination of a fusogenic glycoprotein, prodrug activation, and oncolytic herpes simplex virus for enhanced local tumor control.

R. Coffin, Binlei Liu, G. Campbell, 2006, Cancer research.

THE HUMAN TUMOR-EGG HOST SYSTEM. III. TUMOR-INHIBITORY PROPERTIES OF TENUAZONIE ACID.

H. B. Woodruff, G. Campbell, D. Hendlin, 1964, Cancer research.